A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2004
12/29/2004	WO2004113312A1 Hydroxamate sulfonamides as cd23 shedding inhibitors
12/29/2004	WO2004113302A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/29/2004	WO2004113298A1 Hydroxamate sulfonamides as cd23 shedding inhibitors
12/29/2004	WO2004113279A1 Inhibitors of matrix metalloproteinase
12/29/2004	WO2004112822A1 Synthetic peptide combinations and methods for the production thereof
12/29/2004	WO2004112773A1 Pharmaceutical compositions used for immune disease treatment and improvement
12/29/2004	WO2004087181A8 ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING ω3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF
12/29/2004	WO2004084942A3 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
12/29/2004	WO2003103671A8 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/29/2004	WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	WO2002043648A3 Compounds active at the glucocorticoid receptor ii
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491537A1 Hydroxymorpholinone derivative and medicinal use thereof
12/29/2004	EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
12/29/2004	EP1491208A1 Stabilized liquid polypeptide-containing pharmaceutical compositions
12/29/2004	EP1491203A1 Compositions for treating and/or preventing pollenosis
12/29/2004	EP1491197A1 Pharmaceutical composition comprising voacamine for the stimulation and modulation of the human immunologic system
12/29/2004	EP1491193A1 Therapeutic combinations comprising amlodipine and atorvastatin
12/29/2004	EP1491192A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon
12/29/2004	EP1491187A1 Preventive or therapeutic agent for kidney disease
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490519A2 Life sciences business systems and methods
12/29/2004	EP1490474A2 Method for producing pseudo islets
12/29/2004	EP1490406A1 Costimulatory molecule and its use
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490366A1 Novel alkoxypyridine-derivatives
12/29/2004	EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases
12/29/2004	EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/29/2004	EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
12/29/2004	EP1490355A1 Indolylmaleimide derivatives
12/29/2004	EP1490354A1 4-imidazolyl substituted pyrimidine derivatives with cdk inhibitory activity
12/29/2004	EP1490352A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
12/29/2004	EP1490349A1 Therapeutic ion channel blocking agents and methods of use thereof
12/29/2004	EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators
12/29/2004	EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
12/29/2004	EP1490339A1 Novel chalcone derivatives and uses thereof
12/29/2004	EP1490336A1 Piperidine or 8-aza-bicyclo(3.2.1)oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
12/29/2004	EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490315A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
12/29/2004	EP1490108A2 Drg11-responsive (dragon) gene family
12/29/2004	EP1490101A1 Methods of enhancing immune induction involving mda-7
12/29/2004	EP1490094A1 Antibody fusion proteins: effective adjuvants of protein vaccination
12/29/2004	EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004	EP1490081A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
12/29/2004	EP1490072A1 Novel therapeutical use of agonist ligands specific to g2a receptor
12/29/2004	EP1490070A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
12/29/2004	EP1490069A2 Alpha aed and beta aed regulation of nuclear transcription, gene regulation, and/or gene expression
12/29/2004	EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490044A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
12/29/2004	EP1489924A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
12/29/2004	EP1489915A1 Treatment and prevention of inflammatory disorders
12/29/2004	EP1295606A4 Curing method for pathologic syndrome and a medicinal preparation
12/29/2004	EP1287827B1 Immunopotentiator
12/29/2004	EP1284998B1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
12/29/2004	EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment
12/29/2004	EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/29/2004	EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004	EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/29/2004	EP1196180B1 Treatment of angiogenesis dependent conditions with dextrin sulphate
12/29/2004	EP1176140B1 Amide compounds and medicinal use thereof
12/29/2004	EP1171419B1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
12/29/2004	EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004	EP1148059B1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
12/29/2004	EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004	EP1124576B1 Method for preparing solid phase conjugate vaccines
12/29/2004	EP1123274B1 Substituted phenyl derivatives, their preparation and use
12/29/2004	EP0920632B1 Methods for detection of autoimmune diseases
12/29/2004	EP0909173B1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders
12/29/2004	EP0830130B9 Tnf-alpha converting enzyme
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	EP0722342B1 REGULATION OF bcl-2 GENE EXPRESSION
12/29/2004	CN1558915A Leukocyte inactivation module
12/29/2004	CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558903A Water-soluble phenylpyridazine compounds and compositions containing the same
12/29/2004	CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1557836A Preparation and use for immunosuppressive polypeptides
12/29/2004	CN1557483A Allergy inhibiting prescription
12/29/2004	CN1557482A Immune function regulating and tumor resisting natural nutrient
12/29/2004	CN1557476A Multiple biological activity polypeptide nutrient
12/29/2004	CN1557466A Marrow peptide preparation and its preparing process
12/29/2004	CN1557465A Spleen aminopeptide preparation and its preparing method
12/29/2004	CN1557464A 转移因子片剂 Transfer Factor Tablets
12/29/2004	CN1557423A Chinese traditional medicine for treating allergic rhinitis
12/29/2004	CN1557338A Preparation for preventing and treating rheumatic arthritis and other autoimmune disease
12/29/2004	CN1557328A Application of 20(R)-ginsenoside Rh2 in pharmacy
12/29/2004	CN1557306A Flavescent sophora root essence dispersion tablet
12/29/2004	CN1557296A Gingko lactone freeze dried powder injection and its preparation method
12/29/2004	CN1182247C Sequence-specific DNA recombination in eukaryotic cells
12/29/2004	CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
12/29/2004	CN1182129C Benzopyran derivatives having leukotriene-antagonistic action
12/29/2004	CN1182107C Hydroxamic acid derivative as inhibitor of formation of soluble human CD23
12/29/2004	CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine
12/29/2004	CN1181826C Lipid-based immune regulator composition

1 ... 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 ... 1172